1. Home
  2. XP vs GKOS Comparison

XP vs GKOS Comparison

Compare XP & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XP
  • GKOS
  • Stock Information
  • Founded
  • XP 2001
  • GKOS 1998
  • Country
  • XP Cayman Islands
  • GKOS United States
  • Employees
  • XP N/A
  • GKOS N/A
  • Industry
  • XP Investment Bankers/Brokers/Service
  • GKOS Medical/Dental Instruments
  • Sector
  • XP Finance
  • GKOS Health Care
  • Exchange
  • XP Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • XP 7.4B
  • GKOS 7.4B
  • IPO Year
  • XP 2019
  • GKOS 2015
  • Fundamental
  • Price
  • XP $12.18
  • GKOS $150.97
  • Analyst Decision
  • XP Buy
  • GKOS Strong Buy
  • Analyst Count
  • XP 7
  • GKOS 13
  • Target Price
  • XP $23.57
  • GKOS $145.54
  • AVG Volume (30 Days)
  • XP 8.9M
  • GKOS 623.8K
  • Earning Date
  • XP 11-19-2024
  • GKOS 11-04-2024
  • Dividend Yield
  • XP 11.99%
  • GKOS N/A
  • EPS Growth
  • XP 19.15
  • GKOS N/A
  • EPS
  • XP 1.46
  • GKOS N/A
  • Revenue
  • XP $2,917,445,096.00
  • GKOS $360,347,000.00
  • Revenue This Year
  • XP $23.84
  • GKOS $22.68
  • Revenue Next Year
  • XP $17.31
  • GKOS $24.98
  • P/E Ratio
  • XP $8.36
  • GKOS N/A
  • Revenue Growth
  • XP 18.63
  • GKOS 18.70
  • 52 Week Low
  • XP $11.68
  • GKOS $74.75
  • 52 Week High
  • XP $26.84
  • GKOS $151.12
  • Technical
  • Relative Strength Index (RSI)
  • XP 25.94
  • GKOS 62.92
  • Support Level
  • XP $11.68
  • GKOS $137.60
  • Resistance Level
  • XP $13.23
  • GKOS $147.50
  • Average True Range (ATR)
  • XP 0.50
  • GKOS 5.43
  • MACD
  • XP -0.03
  • GKOS 0.74
  • Stochastic Oscillator
  • XP 21.93
  • GKOS 99.16

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: